OLD DRUG, NEW TREATMENT
Researchers from the University of Manchester have developed a new treatment that could limit the damage caused by strokes and also promote repair in the affected area of the brain. What’s more, the drug they’re using has already been clinically approved.

The researchers’ study is published in Brain, Behavior and Immunity, and it recounts how they developed their treatment using mice bred to develop ischemic strokes, the most prevalent type of stroke and one that occurs when an artery that supplies oxygen-rich blood to the brain is blocked. Soon after the mice experienced a stroke, the researchers treated them with interleukin-1 receptor antagonist (IL-1Ra), an anti-inflammatory drug that is already licensed for use in treating rheumatoid arthritis.

They noticed a reduction in the amount of brain damage typically observed after a stroke and also noted that the drug boosted neurogenesis (the birth of new cells) in the areas that did experience brain damage in the days following the treatment. The mice even regained the motor skills they lost due to the stroke.

CERLUTEN – is a natural non-hormonal bioregulator
obtained from the brain tissue of young animals and is used to restore and maintain the central nervous system and the brain. Its structure consists of the complex of amino acids which influence directly on the DNA structure of the brian, replace damaged or aged molecules and restore the protein synthesis, thus providing optimal functionality of the brain. Cerluten is used to treat and prevent all brain diseases and dysfunctions such as consequences of apoplectic stroke, craniocerebral injury, encephalopathy caused by ischemic аtherosclerosis. Prevents the brain from age-related alterations.

INDICATION FOR USE

Atherosclerosis
After Stroke Therapy
Memory Loss and Lack of Concentration
Alzheimer’s and Parkinson’s Diseases
Multiple Sclerosis
Chronic Fatigue Syndrome
Neuralgia and Peripheral Neuropathy

DOSAGE

Active substance: peptide complex A-5 (peptides from the brain tissue)
Excipients: microcrystalline cellulose (E460), beetroot sugar, lactose, starch, Tween-80
Recommendations for use for adults: 1-2 capsules 1-2 times a day with meals. Duration: 1 month. Repeat every 3-6 months.

By |2018-12-05T09:47:27+00:00May 10th, 2017|Deutsch, English, News, Uncategorised, Uncategorized, Videos|0 Comments

About the Author:

Leave A Comment

Fill out the form or call us at

+46 760 655 769

to set up a free consultation.

Your Name (required)

Your Email (required)

Subject

Your Message